The Task Force shall collect and organize data concerning the nature and extent of neonatal withdrawal syndrome from prescription drugs in Florida; collect and organize data concerning the costs associated with treating expectant mothers and newborns suffering from withdrawal from prescription drugs; identify available federal, state, and local programs that provide services to mothers who abuse prescription drugs and newborns with neonatal withdrawal syndrome; and evaluate methods to increase public awareness of the dangers associated with prescription drug abuse, particularly to women, expectant mothers, and newborns.